Ipsos estimates 1.4 million Canadians now use glucagon-like peptide-1 receptor agonists, or GLP-1s, such as Ozempic, Wegovy and Mounjaro, and suggests that number will triple by 2030 as more people shift to a pill version Eli Lilly has promised
And yet we still havent fully got there, largely because the media demonised statins despite their life-saving potential
"Treatment with semaglutide, at low doses, significantly reduces body weight in almost 80% of obese PCOS patients who were unresponsive to a previous lifestyle plan." - Enrico Carmina, MD This highlights how critical it is to stay consistent with treatment to achieve and maintain these results
By starting with our free assessment quiz, you can determine your eligibility for various programs
Because this is an at-home injection program, your success depends not only on the prescription itself but also on consistency, proper technique, and pairing treatment with habits that support recovery, training, and sleep